CVE-2003-1149

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in Symantec Norton Internet Security 2003 6.0.4.34 allows remote attackers to inject arbitrary web script or HTML via a URL to a blocked site, which is displayed on the blocked sites error page.

4.3

CVSS

Severity: Medium

CVSS 2.0 •

EPSS 2.00% Top 20%

Vendor Advisory secunia.com Vendor Advisory symantec.com Vendor Advisory osvdb.org Vendor Advisory securityfocus.com Vendor Advisory securityfocus.com

Affected: n/a n/a

References

Link	Tags
http://www.securityfocus.com/archive/1/342548	mailing list vendor advisory
http://securityresponse.symantec.com/avcenter/security/Content/2003.10.27.html	vendor advisory
http://www.osvdb.org/2714	exploit vdb entry patch vendor advisory
http://secunia.com/advisories/10067	third party advisory vendor advisory
http://www.securityfocus.com/bid/8904	exploit vdb entry patch vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/13528	vdb entry

Frequently Asked Questions

What is the severity of CVE-2003-1149?: CVE-2003-1149 has been scored as a medium severity vulnerability.
How to fix CVE-2003-1149?: To fix CVE-2003-1149, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2003-1149 being actively exploited in the wild?: It is possible that CVE-2003-1149 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.